{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-029404","form_type":"8-K","ticker":null,"cik":"0001504167","company_name":"TREX WIND-DOWN, INC.","filed_at":"2023-10-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.291128+00:00","generated_at":"2026-06-09T05:51:42.287706+00:00","sec_items":["1.01","2.03","5.07","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Timber Pharma increases bridge loan to $6.5M, adjourns merger vote to Nov 17","bullets":["Bridge loan from LEO US Holding increased by $3.5M to $6.5M total; $1.8M funded Oct 27, $1.7M available after Nov 13.","Special meeting to vote on LEO Pharma merger adjourned to Nov 17, 2023; only 1,039,324 votes for adjournment vs 141,530 against.","Loan amendment includes release of claims by borrowers and proceeds used for working capital and general corporate purposes.","Merger agreement (Aug 20, 2023) still pending stockholder approval; company needs additional time to secure votes."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-029404","json":"https://secwatch.observer/filing/0001437749-23-029404.json","markdown":"https://secwatch.observer/filing/0001437749-23-029404.md","text":"https://secwatch.observer/filing/0001437749-23-029404.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1504167/000143774923029404/0001437749-23-029404-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1504167/000143774923029404/tmbr20231028_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T05:51:42.287706+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"71ffd834afa668308a6aa1e3074226ada55a85c8","claim":"TREX WIND-DOWN, INC. incurred loan of $3.5 million with LEO US Holding, Inc..","evidence_excerpt":"Parent agreed to increase the aggregate amount of the Bridge Loan by $3.5 million","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1504167/000143774923029404/0001437749-23-029404-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"loan"},{"label":"Principal","value":"$3.5 million"},{"label":"Counterparty","value":"LEO US Holding, Inc."},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"c7091fffa0deda3856cbfb99ee1f75385d87b583","claim":"TREX WIND-DOWN, INC. amended First Amendment to the Bridge Loan Agreement with LEO US Holding, Inc., LEO Pharma A/S valued at $3.5 million (effective 2023-10-27).","evidence_excerpt":"On October 27, 2023, Timber, Timber Pharmaceuticals, LLC, BioPharmX, Inc. and Parent entered into the First Amendment to the Bridge Loan Agreement (the “Bridge Loan Amendment”), whereby Parent agreed to increase the aggregate amount of the Bridge Loan by $3.5 million to a total of $6.5 million","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1504167/000143774923029404/0001437749-23-029404-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"LEO US Holding, Inc., LEO Pharma A/S"},{"label":"Value","value":"$3.5 million"},{"label":"Effective","value":"2023-10-27"}],"fact_type":"material_agreement"},{"claim_id":"e15b6c4d7e45ed9dc3e5db93023ca2cbe72479ce","claim":"TREX WIND-DOWN, INC. entered into Secured Bridge Loan Agreement with LEO US Holding, Inc., LEO Pharma A/S valued at $3.0 million (effective 2023-08-30).","evidence_excerpt":"Timber, Timber Pharmaceuticals, LLC, BioPharmX, Inc. Parent entered into a Secured Bridge Loan Agreement (the “Bridge Loan Agreement”), pursuant to which Parent has agreed to loan Timber an aggregate amount of $3.0 million (the “Bridge Loan”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1504167/000143774923029404/0001437749-23-029404-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"LEO US Holding, Inc., LEO Pharma A/S"},{"label":"Value","value":"$3.0 million"},{"label":"Effective","value":"2023-08-30"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}